BioHarvest Sciences Inc. Common Stock (BHST) — Financial Flexibility Index
BioHarvest Sciences Inc. Common Stock (BHST) has a Financial Flexibility Index of -0.09x as of June 2026. Free cash flow of $-2.21 Million (operating CF $-2.77 Million minus capex $562.60K) represents 0% of total liabilities ($24.80 Million). Check BioHarvest Sciences Inc. Common Stock total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BioHarvest Sciences Inc. Common Stock Financial Flexibility Index (2015–2025)
Historical Financial Flexibility Index trend for BioHarvest Sciences Inc. Common Stock across 10 annual periods. For the full cash flow conversion analysis, see BioHarvest Sciences Inc. Common Stock (BHST) cash flow conversion.
Annual Financial Flexibility Index for BioHarvest Sciences Inc. Common Stock (2015–2025)
Year-by-year free cash flow to debt coverage for BioHarvest Sciences Inc. Common Stock. Explore BHST cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.22x | $-4.87 Million | $-7.23 Million | $22.22 Million | ▼ -34.8% |
| 2024 | -0.16x | $-3.85 Million | $-6.68 Million | $23.67 Million | ▲ +31.1% |
| 2023 | -0.24x | $-7.05 Million | $-8.52 Million | $29.86 Million | ▲ +54.7% |
| 2022 | -0.52x | $-7.99 Million | $-9.24 Million | $15.32 Million | ▲ +25.7% |
| 2021 | -0.70x | $-5.15 Million | $-6.79 Million | $7.35 Million | ▼ -43.9% |
| 2020 | -0.49x | $-3.70 Million | $-3.88 Million | $7.60 Million | ▼ -501.3% |
| 2019 | -0.08x | $-2.35 Million | $-2.38 Million | $28.99 Million | ▼ -124.4% |
| 2017 | -0.04x | $-1.00K | $-1.00K | $27.70K | ▲ +94.1% |
| 2016 | -0.62x | $-74.60K | $-74.60K | $121.17K | ▲ +72.4% |
| 2015 | -2.23x | $-126.82K | $-126.82K | $56.86K | — |